🕵️ XOMA Royalty Corp ($XOMAP)
SEC insider & ownership activity, last 12 months · CIK 791908 · every row links its SEC filing
Over the last 12 months insiders sold $156K against $2.5M of open-market buying. Hughes Owen bought $2.5M in discretionary trades (Dec). One red-flag 8-K in the window: Delisting notice (3.01), Jul 13, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $2.5M (1 lots) · 1 seller, $156K (3 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Hughes Owen | 1 | $2.5M | 0 | – | Dec 4, 2025 |
| Thomas M. Burns | 0 | – | 3 | $156K | Sep 22, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | 47.0% | 13D | Apr 27, 2026 | filing ↗ | |
| Morgan Stanley | 13.7% | 13G | Feb 12, 2026 | filing ↗ | |
| Morgan Stanley Investment Management Inc. | 13.7% | 13G | Feb 12, 2026 | filing ↗ | |
| FMR LLC | 10.2% | 13G | Mar 6, 2026 | filing ↗ | |
| Abigail P. Johnson | 10.2% | 13G | Mar 6, 2026 | filing ↗ | |
| Blackrock, Inc. | 5.4% | 13G | Apr 27, 2026 | filing ↗ | |
| Woodline Partners LP | 5.4% | 13G | May 15, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.2% | 13G | Apr 30, 2026 | filing ↗ | |
| BVF Partners L P/IL | exited | 13D | Jul 14, 2026 | filing ↗ | |
| Biotechnology Value Fund L P | exited | 13D | Jul 14, 2026 | filing ↗ | |
| BVF I GP LLC | exited | 13D | Jul 14, 2026 | filing ↗ | |
| Biotechnology Value Fund II LP | exited | 13D | Jul 14, 2026 | filing ↗ | |
| BVF II GP LLC | exited | 13D | Jul 14, 2026 | filing ↗ | |
| Biotechnology Value Trading Fund OS LP | exited | 13D | Jul 14, 2026 | filing ↗ | |
| BVF Partners OS Ltd. | exited | 13D | Jul 14, 2026 | filing ↗ | |
| BVF GP Holdings LLC | exited | 13D | Jul 14, 2026 | filing ↗ | |
| BVF INC/IL | exited | 13D | Jul 14, 2026 | filing ↗ | |
| Mark N. Lampert | exited | 13D | Jul 14, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Agreement terminated (1.02) | Jul 13, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Jul 13, 2026 | filing ↗ |
| Delisting notice (3.01) | Jul 13, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Jul 13, 2026 | filing ↗ |
| Change of control (5.01) | Jul 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 13, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jul 13, 2026 | filing ↗ |
| Other events (8.01) | Jul 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 12, 2026 | filing ↗ |
| Other events (8.01) | Jun 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 21, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | May 21, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 21, 2026 | filing ↗ |
| Material agreement (1.01) | May 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 16, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 27, 2026 | filing ↗ |
| Other events (8.01) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Earnings (2.02) | Mar 18, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 18, 2026 | filing ↗ |
| Earnings (2.02) | Mar 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 2, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Feb 9, 2026 | filing ↗ |
| Other events (8.01) | Feb 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 9, 2026 | filing ↗ |